September 18, 2025Frontiers in MicrobiologyOpen Access

Interaction mechanism and intervention strategy between metabolic dysfunction-associated steatotic liver disease and intestinal microbiota

View Full Paper

Ask AI

Bookmark

Authors

WYWei Cheng YangGuangzhou University of Chinese Medicine QJQing JinUniversity of Southern California DXDewang Xiao

Discussion

Member takes

Implication

This analysis reveals interactions between metabolic dysfunction-associated steatotic liver disease and intestinal microbiota, suggesting probiotics and dietary strategies may alleviate damage.

Key Points

Short-chain fatty acids deficiency contributes to inflammation, while probiotics like Bifidobacteria can improve microbiota.
Interventions such as the Mediterranean diet and restricted fructose intake may reduce liver damage through microbiota regulation.
Fecal microbiota transplantation showcases potential but requires optimization for safety in clinical applications.
Future approaches integrating multi-omics technology could lead to personalized therapies for metabolic dysfunction.

Cite This Study

Yang et al. (2025) studied this question.

synapsesocial.com/papers/68d435cf713b0b5dfea74eed https://doi.org/10.3389/fmicb.2025.1597995

View Full Paper

Ask AI

Bookmark

Implication

This analysis reveals interactions between metabolic dysfunction-associated steatotic liver disease and intestinal microbiota, suggesting probiotics and dietary strategies may alleviate damage.

Interaction mechanism and intervention strategy between metabolic dysfunction-associated steatotic liver disease and intestinal microbiota

Discussion

Member takes

Implication

Key Points

Cite This Study

Interaction mechanism and intervention strategy between metabolic dysfunction-associated steatotic liver disease and intestinal microbiota

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider